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SUMMARY
During African trypanosomiasis, macrophages play a cen-
tral role in T cell hyporesponsiveness to parasite-related
and unrelated antigens. In this study, the ability of macro-
phages from Trypanosoma b. brucei-infected mice to pre-
sent exogenous antigens to a major histocompatibility
complex (MHC) class II-restricted CD4 T cell hybridoma
was analysed. We demonstrate that the antigen presentation
capacity of macrophages from infected mice is markedly
reduced as a result of a lower expression of [MHC class II-
peptide] complexes on their plasma membrane. This defect
did not result from a decreased antigen uptake/catabolism, a
reduced MHC class II and intercellular adhesion molecule 1
expression on the surface of macrophages, a decreased
af®nity of MHC class II molecules for antigenic peptides,
a competition between exogenous and parasite antigens, or
the generation of inhibitory peptides. Our data indicate that
the step resulting in coexpression of processed antigens and
MHC class II molecules is affected in T. b. brucei-infected
mice. Additionally, macrophages from infected mice
secreted IL-10 that in turn contributes to the impairment
of T cell activation.
Keywords Trypanosoma, antigen presentation, immuno-
suppression
INTRODUCTION
African trypanosomes are extracellular haemoparasites
causing the diseases sleeping sickness in humans or its
animal counterpart nagana in sub-Saharan Africa. These
parasites evade the host's immune response through anti-
genic variation (Borst & Rudenko 1994). Moreover, they
inhibit T cell proliferative responses to parasite-related and
-unrelated antigens (Schleifer & Mans®eld 1993, Beschin
et al. 1998, Sternberg 1998). The trypanosome-induced T
cell suppression may be responsible for the increased
susceptibility of infected animals to secondary infections,
as well as their poor responsiveness to vaccination (Ruran-
girwa et al. 1978, Kaufmann et al. 1992). Although many
mechanisms have been proposed to explain the induction of
this immunosuppression, cumulative evidence indicates that
suppressive macrophages elicited during infection are
important effector cells in the impairment of lympho-
proliferative responses during African trypanosomiasis
(Sileghem et al. 1989a, Borrowy et al. 1990, Schleifer &
Mans®eld 1993, Sternberg 1998).
In addition to their effector functions, macrophages play a
central role in the immune response as antigen presenting
cells. This function includes protein antigen uptake, antigen
processing in the acidic compartment of the endocytic
pathway, and presentation of the resultant antigenic peptides
to antigen-speci®c CD4 T cells in the context of major
histocompatibility complex (MHC) class II molecules (Buus
et al. 1987, Pierre & Mellman 1998). Furthermore, adhesion
and costimulatory molecules are required to fully activate
CD4 T cells (Swain 1999, Watts & De Benedette 1999).
Modulation of antigen presentation function at any of these
levels is a potential way for parasites to evade the immune
system.
To date, despite the pivotal role played by macrophages
in T cell hyporesponsiveness in African trypanosome-
infected animals, little attention has been paid to the
possible alterations of their antigen presentation capacity.
An increase in macrophage phagocytic activity during
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infection with Trypanosoma b. brucei has been described in
mice (Stevens & Moulton 1978, Grosskinsky & Askonas
1981) and livestock (MacKenzie et al. 1978, Kissling et al.
1982). Infection with T. b. brucei is also associated with
up-regulation of MHC class II molecules expression on
macrophages, and increased secretion of IL-1, prostaglan-
dins, nitric oxide (NO) and tumour necrosis factor (TNF)-a
by macrophages (Grosskinsky & Askonas 1981, Sileghem
et al. 1989b, Schleifer & Mans®eld 1993, Darji et al. 1996,
Beschin et al. 1998, Magez et al. 1998). In contrast, Bagasra
and coworkers found that MHC class II macrophages are
depleted during murine T. b. rhodesiense infection (Bagasra
et al. 1981). Moreover, IL-1 secretion and antigen presen-
tation were shown to be impaired in mice infected with
T. b. rhodesiense (Paulnock et al. 1988) or T. congolense
(Mitchell et al. 1986).
To gain further insights into the accessory cell function of
macrophages during T. b. brucei infection, the ability of
macrophages from infected mice to present hen egg lyso-
zyme (HEL) or a derived immunogenic peptide (HEL-
peptide) to MHC class II-restricted CD4 T cell hybridoma
was evaluated. We show that T. b. brucei infection results in
an impairment of macrophage antigen presentation capacity
in the spleen, the lymph nodes and the peritoneal cavity.
Intracellular events leading to the coupling of antigenic
peptides and MHC class II molecules may underlie this
defect. Moreover, macrophages from T. b. brucei-infected
mice secrete factors, including IL-10, that contribute to
inhibit T cell activation.
MATERIALS AND METHODS
Parasites and animals
Pleomorphic T. brucei brucei AnTat 1´1E post ¯y clone,
kindly provided by Dr N.Van Meirvenne (Institute of
tropical Medicine, Antwerp, Belgium), was used to infect
8±12 week-old female Balb/c mice (Harlan, Zeist, The
Netherlands). Mice were inoculated intraperitoneally with
2 ´ 103 viable bloodstream form parasites and survived for
30 days postinfection. Parasitemia was monitored by tail
blood puncture at 2-day intervals using a counting chamber.
Antigen presenting cells and T cell hybridoma
Adherent cell population from the spleen, the lymph nodes
and the peritoneal cavity of noninfected and T. b. brucei-
infected mice, prepared as described (Beschin et al. 1998),
were resuspended in RPMI 1640 medium (Gibco, Merel-
beke, Belgium) supplemented with foetal calf serum (10%),
penicillin-streptomycin (100 U±100 mg/ml), L-glutamine
(2 mM) and 2-mercaptoethanol (5 ´ 10ÿ5 M; complete
medium). Plastic adherent cells, containing 95% MAC-1-
positive cells as determined by FACS analysis, were con-
sidered as macrophages and used as antigen presenting cells.
When required, macrophages were ®xed with glutaralde-
hyde (0´05%) as described (Scorza et al. 1999).
The mouse 1E5´11 T cell hybridoma (I-Ed-restricted)
reactive to HEL or its derivative peptide (residues 105±
120), kindly provided by Dr A. Darji (GBF, Braunschweig,
Germany), was propagated in complete medium.
Conditioned media
Macrophages (2 ´ 106/ml) from noninfected or T. b. brucei-
infected mice were incubated overnight at 378C in complete
medium. Culture supernatants were collected, centrifuged
and kept at ÿ208C until use.
Antigen presentation assay
The T cell hybridoma (2 ´ 105/ml) was cocultured in com-
plete medium with antigen presenting cells (5 ´ 105/ml) in
presence of HEL (Merck, Overijse, Belgium, 50 mg/ml) or
equivalent molar concentration of HEL-peptide (synthe-
sized by Genosys, Cambridge, UK, 7 mg/ml) at 378C in a
humidi®ed atmosphere containing 5% CO2. Activation of the
T cell hybridoma was determined by measuring IL-2 content
in the 24-h coculture supernatants using a speci®c ELISA
(Pharmingen, Erembodegem-Aalst, Belgium) as previously
described (Scorza et al. 1999).
To test the in¯uence of soluble factors on T cell activa-
tion, conditioned medium from noninfected or T. b. brucei-
infected mice (25%) was added to cocultures of antigen
presenting cells from noninfected mice and T cell hybrid-
oma. In some experiments, conditioned media were pre-
incubated with neutralising anti-IL-10 or isotype matched
irrelevant antibody (Pharmingen, Cat. 18431 A or Cat.
20180D, 25 mg/ml) before addition to cocultures.
Uptake and catabolism of HEL protein
HEL was radio-labelled with 125I using Iodo-beadsÒ iodi-
nation reagent as speci®ed by the manufacturer (Pierce,
Antwerpen, Belgium) to a speci®c activity of 1´3±
4´0 ´ 106 cpm/mg. Macrophages were allowed to adhere on
35 mm tissue culture plates (2 h, 378C), then incubated for
3 h at 378C with radiolabelled HEL (6 mg/2 ´ 105 cells/ml).
Cells were washed (1% BSA in PBS) until no radioactivity
could be detected in the washing medium, lysed in Triton X-
100 (0´5% in PBS), and the total amount of incorporated
radioactivity was measured. The radioactivity released from
macrophages incubated with 125I-labelled HEL in the pre-
sence of 0´2 mM sodium azide to block endocytosis was
subtracted to calculate the net HEL uptake.
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To determine the antigen catabolism, macrophages were
loaded with 125I-labelled HEL and washed as described
above. Cells were then chased for 0±180 min at 378C in
HEL-free medium. The 10% trichloroacetic acid (TCA)-
soluble and insoluble radioactivity present in the cell lysate
or culture medium supernatants were measured. In control
experiments, macrophages incubated with 125I-labelled
HEL were chased in medium containing sodium azide.
The radioactivity released from the appropriate controls
was subtracted to ®nd out the net HEL catabolism.
Expression of surface molecules on antigen
presenting cells
Biotinylated anti-I-Ed, anti-ICAM-1, anti-CD40, anti-MAC-1
and isotype control antibodies used for cyto¯uorimetry
analysis were purchased from Pharmingen. CTLA-4/Ig,
used to detect the surface expression of B7, was a kind
gift of Dr K.Thielemans (Allergy/Immunology, Internal
Medicine, Vrije Universiteit Brussels, Belgium). FITC-
conjugated streptavidin and FITC-labelled anti(human)
IgG were obtained, respectively, from Amersham Life
Science (Bucks, UK) and Serotec (Oxford, UK). All incuba-
tions were performed for 30 min on ice. Macrophages were
incubated with normal rabbit serum (12%) to block Fc-
receptor, before addition of the staining antibody (1 mg/106
cells). After washings, cells were incubated with appro-
priated FITC-labelled molecule (diluted as suggested by the
provider) and washed again. Stained cells were analysed on
a Becton Dickinson FACStar (Erembodegem-Aalst, Bel-
gium) using the CELLQuest programme. Isotype control
antibodies did not show signi®cant background staining.
Statistical analysis
For each parameter, means (6 SD) of triplicate cultures
were calculated. Results are representative of at least four
independent similar experiments performed. Statistical ana-
lyses were assessed by Student's t-test (one-way) to validate
the data.
RESULTS
Presentation of HEL by macrophages from
T. b. brucei-infected mice
The ability of macrophages from the spleen, lymph node and
peritoneal compartments of T. b. brucei-infected mice
(respectively sMF-I, lnMF-I, pMF-I) to present HEL to a
speci®c MHC class II-restricted T cell hybridoma was
evaluated during the whole course of infection. Figure 1
shows representative results of two time-points postinfection,
namely during the early (®rst peak of parasitemia) and late
(®fth week) stage of infection. Compared to macrophages
from noninfected mice, sMF-I, lnMF-I and pMF-I were
impaired in their capacity to present HEL during the course
of infection. However, while the antigen presentation capa-
city of pMF-I was nearly completely inhibited at both early
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Figure 1 Macrophages from the spleen, lymph nodes and peritoneal cavity of T. b. brucei-infected mice are impaired in their antigen presentation
capacity. HEL-speci®c T cell hybridoma was cocultured for 24 h with various concentrations of macrophages from the spleen (a), lymph nodes
(b) and peritoneal cavity (c) of noninfected (W) or T. b. brucei-infected mice (A early or B late stage of infection) in presence of HEL protein
(50 mg/ml). T cell activation was monitored by quantifying IL-2 in coculture supernatants using IL-2-speci®c ELISA. (*) IL-2 production
signi®cantly lower in cocultures including macrophages from late stage of infection than in cultures containing macrophages from noninfected
mice (P < 0´05). (#) IL-2 production signi®cantly lower in cocultures including macrophages collected during the early and late stages of infection
compared to cocultures containing macrophages from noninfected mice (P < 0´01).
and late stages of infection, the antigen presentation func-
tion of sMF-I and lnMF-I was only signi®cantly reduced
during the late stage of infection. The presentation of HEL-
peptide by sMF-I, lnMF-I and pMF-I was also reduced at
both early and late stages of T. b. brucei infection but to a
lesser extent than the presentation of HEL protein (not
shown). These results indicate that inhibition of the antigen
presentation capacity of macrophages occurs, although at
different times following infection, in three lymphoid com-
partments of T. b. brucei-infected mice. Peritoneal macro-
phages from late stage-infected mice were thus chosen to
further analyse the mechanisms by which antigen presenting
cells impair T cell activation.
In¯uence of T. b. brucei infection on uptake and
catabolism of HEL protein by macrophages
The antigen presentation function of pMF-I was not restored
by increasing the HEL concentration, and remained reduced
by 50% compared to peritoneal macrophages from non-
infected animals (pMF-N) at optimal HEL or HEL-peptide
concentration (P < 0´05) (Figure 2).
To test whether the impaired antigen presentation capacity
resulted from a defective antigen uptake, pMF-I were incu-
bated with 125I-HEL during 3 h at 378C. As shown in Table 1,
the total amount of cell-associated radioactivity was approxi-
mately two-fold higher in pMF-I than in pMF-N. Antigen
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Figure 2 Antigen presentation capacity of macrophages from T. b. brucei-infected mice is not restored by increasing antigen concentration. pMF-
N (W) or pMF-I (B) were incubated with T cell hybridoma in presence of various concentrations of HEL protein (a) or HEL-peptide (b). T cell
activation was determined as described in Figure 1. (*) IL-2 production signi®cantly lower in cocultures containing pMF-I than in cocultures
containing pMF-N (P < 0´05).
PMF-N pMF-I
Uptake (c.p.m./5 ´ 105 cells)a 6947 6 106 14328 6 209
Catabolism (TCA-soluble radioactivity,
c.p.m./5 ´ 105 cells) afterb
0 min 1081 6 96 (16%) 4387 6 122 (31%)c
30 min 2090 6 103 (30%) 8091 6 120 (56%)c
90 min 3921 6 136 (56%) 12999 6 225 (91%)c
180 min 5203 6 181 (75%) 10096 6 213 (70%)
apMF-N or pMF-I were incubated with 125I-HEL for 3 h at 378C. After washing, the total
amount of incorporated radioactivity was determined as described in materials and methods.
bCells were chased in HEL-free medium for various times. Catabolism, expressed as released
and cell-associated TCA-soluble radioactivity was measured as described in materials and
methods. Values in brackets represent the percentage of catabolized antigen compared to the
uptake. cHEL catabolism higher in pMF-I than in pMF-N (P < 0´05).
Table 1 Uptake and catabolism of
125I-HEL-protein by macrophages from
T. b. brucei-infected mice
catabolism, i.e. the production of immunogenic fragments,
measured on HEL-loaded cells chased in HEL-free medium,
also increased signi®cantly in pMF-I compared to pMF-N.
These data indicate that, following infection with T. b.
brucei, the ability of peritoneal macrophages to ingest and
degrade native protein antigen is upregulated. Therefore the
uptake of exogenous protein and production of peptidic
fragments are not the limiting factors underlying the
reduced antigen presentation capacity of pMF-I.
Presentation of HEL by ®xed macrophages from
T. b. brucei-infected mice
To investigate whether the decreased antigen presentation
capacity of pMF-I re¯ected a reduced expression of [MHC
class II-antigen] complexes on their plasma membrane,
pMF-I were exposed to HEL protein or HEL-peptide for
various time intervals, and subsequently ®xed with glutar-
aldehyde before incubation with the T cell hybridoma. T cell
activation by ®xed pMF-N reached maximal values after 6 h
of incubation with HEL (Figure 3a). However, ®xed pMF-I
displayed an impaired ability to stimulate the T cell hybrid-
oma, even when preincubated with HEL for 24 h (P < 0´01).
These data indicate that following T. b. brucei infection,
pMF-I express less [MHC class II-antigen] complexes on
their surface.
In contrast, ®xation of pMF-I preincubated with HEL-
peptide did not only restore, but signi®cantly increased their
antigen presentation capacity (P < 0´01) (Figure 3b). Simi-
larly, pre®xed pMF-I pulsed with HEL-peptide also dis-
played an enhanced antigen presentation capacity (Table 2).
These data suggest that pMF-I express functional MHC
class II molecules that bind and present immunogenic
peptide to the T cell hybridoma. In addition, a competition
between HEL and parasite antigens for MHC class II
molecules resulting in a reduced formation of [MHC class
II-HEL-peptide] complexes on the surface of pMF-I is
unlikely to occur during T. b. brucei infection.
Finally, to test whether pMF-I generated inhibitory
peptides, pMF-I were prepulsed overnight with or without
an excess of HEL protein. The cells were then ®xed and
pulsed with HEL-peptide before incubation with the T cell
hybridoma. HEL-prepulsed and ®xed pMF-I presented
immunogenic peptide more ef®ciently than ®xed pMF-I
only pulsed with HEL-peptide (Table 3). Hence, the
decreased antigen presenting ability of pMF-I is not due
to the generation of inhibitory peptides during the process-
ing of HEL protein.
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Figure 3 Presentation of HEL by ®xed macrophages from T. b. brucei-infected mice. pMF-N (W) or pMF-I (B) prepulsed with HEL-protein
(a) 50 mg/ml or HEL-peptide (b) 7 mg/ml for various time periods were ®xed and cocultured with T cell hybridoma. T cell activation was
monitored as described in Figure 1. (*) IL-2 production signi®cantly lower in cocultures containing pMF-I than in cocultures containing pMF-N
(P < 0´01). (#) IL-2 production signi®cantly higher in cocultures containing pMF-I than in cocultures containing pMF-N (P < 0´01).
Quanti®cation of plasma membrane-associated
molecules involved in T cell activation on
macrophages during T. b. brucei infection
Since the antigen presentation de®ciency of pMF-I may
result from lower expression of MHC class II, ICAM-1, B7
and/or CD40 molecules (Watts & De Benedette 1999), their
levels on peritoneal macrophage membranes were quanti®ed
by ¯ow cytometry. Compared to pMF-N, the expression
of both MHC class II and ICAM-1 molecules tended to be
upregulated on the surface of pMF-I (Figure 4). Hence,
the impaired antigen presentation by pMF-I does not
result from a reduced expression of MHC class II
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Table 2 Presentation of HEL-peptide by pre®xed macrophages from
T. b. brucei-infected mice
IL-2 production (pg/ml)a
Macrophage pre®xation pMF-N pMF-I
No 543 6 55 88 6 10b
Yes 600 6 58 2038 6 194c,d
apMF-N or pMF-I, pre®xed or not with glutaraldehyde, were
cocultured with T cell hybridoma in presence of HEL peptide. IL-2
produced by T cell hybridoma was determined. bIL-2 production
lower than in cocultures containing pMF-N (P < 0´01). cIL-2
production higher than in cocultures containing pMF-N (P < 0´01).
dIL-2 production higher than in cocultures containing non®xed pMF-I
(P < 0´01).
Table 3 Presentation of HEL-peptide by macrophages from
T. b. brucei-infected mice ®xed after prepulsing with HEL protein
IL-2 production (pg/ml)a
HEL prepulsing HEL-peptide pMF-N pMF-I
ÿ ÿ ND ND
 ÿ 472 6 49 130 6 17b
ÿ  740 6 80 3043 6 228c
  697 6 48 3748 6 294c,d
apMF-N or pMF-I, prepulsed or not overnight with an excess of HEL
protein, were ®xed and pulsed or not with HEL-peptide before
incubation with T cell hybridoma. IL-2 produced by T cell hybridoma
was determined (ND, not detectable). bIL-2 production lower than in
cocultures containing pMF-N (P < 0´01). cIL-2 production higher than
in cocultures containing pMF-N (P < 0´01). dIL-2 production higher
than in cocultures containing pMF-I not prepulsed with HEL protein
(P < 0´05).
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Figure 4 Expression of MHC class II, ICAM-1, B7 and CD40 molecules on macrophages from T. b. brucei-infected mice. Membrane expression
of MHC class II, ICAM-1, B7 and CD40 molecules on pMF-N (upper panel) or pMF-I (lower panel) was determined by ¯ow cytometry. Shaded
peaks represent cells stained with isotype matched irrelevant antibody.
molecules or ICAM-1 adhesion molecules on their plasma
membranes.
In contrast, levels of B7 and CD40 were clearly down-
regulated on pMF-I compared to pMF-N, suggesting a
possible involvement of these costimulatory molecules in
the impaired T cell activation occurring in T. b brucei-
infected mice.
Contribution of soluble mediators to the impaired
antigen presentation capacity of macrophages from
T. b. brucei-infected mice
As mentioned above, ®xed pMF-I displayed an enhanced
ability to present HEL-peptide, suggesting that live pMF-I
secrete mediators impairing T cell hybridoma activation.
This was con®rmed by adding conditioned media from
pMF-I (CM-I) to cocultures of pMF-N and T cell hybrid-
oma in presence of HEL protein or HEL-peptide. As shown
in Figure 5, CM-I signi®cantly inhibited the presentation of
HEL by pMF-N (P < 0´05), and similar effect was observed
for the presentation of HEL-peptide (not shown).
During T. b. brucei infection, macrophages secrete prosta-
glandins, NO and hydrogen peroxide that nonspeci®cally
suppress T cell activation (Sileghem et al. 1989a,c, Schleifer
& Mans®eld 1993, Beschin et al. 1998). However, treatment
of pMF-I with prostaglandins, NO or hydrogen peroxide
inhibitors (respectively indomethacin, NG-monomethyl-L-
arginine or catalase) did not signi®cantly restore the produc-
tion of IL-2 by the T cell hybridoma (not shown), indicating
that these mediators do not contribute to the suppressive
phenotype of pMF-I during HEL presentation.
Cytokines secreted by pMF-I may represent other can-
didates mediating the impairment of T cell activation. To test
this possibility, levels of IL-4, IL-6, IL-10, IFN-g and TNF-a
produced by pMF-I were quanti®ed by speci®c ELISA. Only
the level of IL-10 was found to be increased in pMF-I culture
supernatants compared to pMF-N culture supernatants (not
shown). We thus assessed the possible involvement of IL-10
in the reduction of T cell activation. Figure 5 shows that a
neutralizing anti-IL-10 antibody, did not in¯uence T cell
activation in presence of conditioned media from pMF-N
(CM-N). In contrast, preincubation of CM-I with anti-IL-10
antibody partially but signi®cantly restored IL-2 production
by the T cell hybridoma (P< 0´05), indicating that IL-10
secreted by pMF-I contributes in the impairment of T cell
activation in T. b. brucei-infected mice.
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Figure 5 Involvement of IL-10 in the impaired T cell activation induced by macrophages from T. b. brucei-infected mice. Conditioned medium
from pMF-N or pMF-I, preincubated with neutralizing anti-IL-10 (B) or isotype matched irrelevant (A) antibody, was added to cocultures of
pMF-N and T cell hybridoma in presence of HEL-protein (50 mg/ml). T cell activation was monitored as described in Figure 1. (*) IL-2 production
signi®cantly lower in presence of conditoned medium from pMF-I than from pMF-N (P < 0´01). (#) Signi®cant restoration of IL-2 production in
presence of anti-IL-10 antibody compared to irrelevant antibody (P < 0´01).
DISCUSSION
In this study, using HEL as a model antigen, we show
that T. b. brucei infection reduces the ability of murine
macrophages from the spleen, the lymph nodes and the
peritoneal cavity to stimulate a MHC class II-restricted
antigen-speci®c T cell hybridoma. Although the decreased
antigen presentation ef®ciency of pMF-I was analysed in
depth, similar mechanisms were found to be involved in the
three lymphoid compartments (not shown).
The reduced antigen presentation ef®ciency of pMF-I
results from a lower expression of [MHC class II-antigen]
complexes on their plasma membranes. Several explana-
tions for this defect were excluded. (i) Neither altered
uptake, nor reduction in the generation of peptidic fragments
accounted for the reduced expression of [MHC class II-
antigen] complexes. (ii) T. b. brucei did not inhibit MHC
class II presentation by downregulating the expression of
MHC class II molecules on macrophage surface. In addition,
a downregulation of ICAM-1 adhesion molecule could not
account for the suboptimal activation of the T cell hybrid-
oma. (iii) A decreased expression of other adhesion mole-
cules, or of costimulatory molecules is unlikely to be
involved in the de®cient activation of the T cell hybridoma
since pre®xed pMF-I exhibited an increased ability to
present HEL-peptide compared to pMF-N. However, we
can not exclude that the decreased expression of B7 and
CD40 costimulatory molecules on pMF-I has implications
on the function of antigen presenting cells in T. b. brucei-
infected animals. (iv) A reduced antigen af®nity for the
MHC class II-peptide-binding cleft and a decreased recog-
nition of [MHC class II-antigen] complexes by the T cell
hybridoma were also ruled out since pre®xed pMF-I pre-
sented HEL-peptide more ef®ciently than pMF-N. (v) A
competition between HEL-peptide and parasite antigens,
reducing the formation of [MHC class II-antigen] com-
plexes does not probably occur, since T cell activation
was not restored by incubating pMF-I for 24 h with HEL
before testing their antigen presentation capacity. (vi) Finally,
the possible generation of inhibitory peptides by antigen
presenting cells from T. b. brucei-infected mice seems
unlikely since HEL-prepulsed and ®xed pMF-I, subse-
quently incubated with HEL-peptide were more ef®cient
than ®xed pMF-I pulsed with HEL-peptide alone to activate
T cell hybridoma.
The inhibition of the antigen presentation capacity
required an active T. b. brucei infection since macrophages
from noninfected mice pulsed in vitro with parasite lysate or
glutaraldehyde-®xed parasites did not impair T cell activa-
tion in presence of HEL (not shown). Our data suggest that
the most plausible hypothesis explaining the reduced anti-
gen presentation capacity of pMF-I is interference with the
intracellular loading of antigenic peptides onto MHC class II
molecules during the late stage processing of exogenous
proteins as described during Leishmania or Mycobacterium
infection (Pancholi et al. 1993, Kima et al. 1996). Such
interference may result from the release of biologically
active factors from living trypanosomes, impairing the
vesicular traf®c within macrophages from infected animals
(Tizard et al. 1978, Leyva-Cobian & Unanue 1988, Kima
et al. 1996). Moreover, poorly degradable T. b. brucei
components, such as phospholipids, could impede the
encounter between MHC class II molecules and the pro-
cessed peptides leading to the expression of empty MHC
class II molecules on antigen presenting cell surface from
infected mice (Leyva-Cobian & Unanue 1988). This notion
is supported by our observation that ®xed pMF-I presented
HEL-peptide more ef®ciently than pMF-N, and could
explain the lack of competition of parasite antigens with
HEL-peptide for MHC class II molecule binding.
In addition to an impaired processing/presentation capa-
city, pMF-I secrete mediators contributing to the inhibition
of T cell activation. Prostaglandins, NO, or hydrogen per-
oxide, reported to suppress T cell proliferation during African
trypanosome infection (Sileghem et al. 1989c, Schleifer &
Mans®eld 1993, Beschin et al. 1998) were not signi®cantly
involved in the downregulation of T cell activation. In
addition, speci®c factors such as IFN-g and TNF-a, that
have been shown to mediate T cell hyporesponsiveness
during African trypanosomiasis (Darji et al. 1996, Beschin
et al. 1998, Magez et al. 1999), do not contribute to the
de®cient T cell activation in our model as treatment of
cocultures of pMF-I and T cell hybridoma with neutralising
anti-IFN-g or anti-TNF-a antibodies did not restore IL-2
secretion (not shown). In contrast, the reduced ability of
pMF-I to activate the T cell hybridoma was partially
mediated by IL-10, a cytokine known to inhibit antigen
presentation (Howard & O'Garra 1992, Ding et al. 1993).
Our data suggest that the mechanisms underlying the
defective antigen presentation capacity of macrophages
are very similar in T. b. brucei and Plasmodium chabaudi
parasite-infected mice (Scorza et al. 1999). However, the
mechanisms by which antigen presenting cells from T. b.
brucei-infected animals inhibit T cell activation present
some differences compared to Trypanosoma cruzi or Leish-
mania sp. infected mice. First, macrophages from T. cruzi-
infected animals displayed fewer functional MHC class II
molecules on their membranes (Plasman et al. 1995, La
Flamme et al. 1997). Moreover, they showed a decreased
ability to take up and catabolize exogenous antigens. Second,
the decreased antigen presentation capacity of macrophages
from T.cruzi or Leishmania sp. infected mice was suggested
to result from a competition between exogenous and parasite
antigens (Prina et al. 1993, Plasman et al. 1995, Overath &
B.Namangala et al. Parasite Immunology
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Aebischer 1999). Third, killed Leishmania sp. induced in
vitro a similar infection-associated de®ciency in antigen
presentation of macrophages (Prina et al. 1993). It may well
be that the location (compartmentalization) of the parasites
within the host, i.e. extracellular (T. b. brucei) versus intra-
cellular (T. cruzi, Leishmania sp.) in¯uences the mechan-
isms underlying the defective antigen presentation capacity
of macrophages.
In summary, our results show that T. b. brucei interferes
with the presentation of MHC class II-restricted antigen by
macrophages. Our data favour the hypothesis that the step
resulting in coexpression of processed antigens and MHC
class II molecules on antigen presenting cell surface is
affected in T. b. brucei-infected mice. In addition, macro-
phages from infected animals secrete factors, including
IL-10, contributing to the impairment of T cell activation.
Overall, these defects may contribute to the global immuno-
suppression elicited during African trypanosomiasis and
enable evasion of immune killing by the parasite.
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